Treatment of nucleoside reverse transcriptase inhibitor-induced lactic acidosis.
Brinkman
K
K
Vrouenraets
S
S
Kauffmann
R
R
Weigel
H
H
Frissen
J
J
D000140:Acidosis, Lactic / Q000097:blood / Q000139:chemically induced* / Q000188:drug therapy* / Q000503:physiopathology; D001205:Ascorbic Acid / Q000008:administration & dosage / Q000627:therapeutic use; D001794:Blood Pressure; D002331:Carnitine / Q000008:administration & dosage / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D015203:Reproducibility of Results; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects*; D015996:Survival Rate; D014451:Ubiquinone / Q000008:administration & dosage / Q000627:therapeutic use; D014803:Vitamin B Complex / Q000008:administration & dosage / Q000627:therapeutic use
D018894:Reverse Transcriptase Inhibitors; D014803:Vitamin B Complex; D014451:Ubiquinone; D001205:Ascorbic Acid; D002331:Carnitine